Replies to post #218729 on Biotech Values

[DewDiligence]

Mavyret's NRx% reached new high of 47.6% in week ending 4/20/18 (according to IMS)—besting its previous high by 300 basis points.

This is consistent with what ABBV's CEO said on yesterday's CC (#msg-140326662).